Trial: 201712097

A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (Cetiri) in Advanced/Metastatic Colorectal Cancer (MCRC) with Her-2 Applification

Phase

II

Principal Investigator

Tan, Benjamin

Disease Site

Colon; Rectum

Learn more about this study at: clinicaltrials.gov